Phase I/II study of R435 (Bevacizumab) in patients with metastatic colorectal cancer
收藏NIAID Data Ecosystem2026-03-06 收录
官方服务：
资源简介：
Interventions: investigational material(s) Generic name etc : Bevacizumab INN of investigational material : Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : Injection Primary outcome(s): Initial safety, PK parameter of bevacizumab Study Design: Open, Single Arm study
创建时间：
2005-09-15
